Adaptive Biotechnologies to Present at the BofA Securities 2020 Healthcare Conference

Rhea-AI Summary

Adaptive Biotechnologies (Nasdaq: ADPT) announced its participation in the BofA Securities Virtual Healthcare Conference on May 6, 2020. Management will present on May 13 at 12:00 p.m. Pacific Time / 3:00 p.m. Eastern Time. A live and archived webcast of the presentation will be accessible on the company’s website. Adaptive Biotechnologies focuses on utilizing the adaptive immune system for clinical applications in diagnosing and treating diseases, with a pipeline that includes products for cancer, autoimmune diseases, and infections.

SEATTLE, May 06, 2020 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming BofA Securities Virtual Healthcare Conference.

Adaptive Biotechnologies’ management is scheduled to present on Wednesday, May 13th at 12:00 p.m. Pactific Time / 3:00 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.adaptivebiotech.com.

About Adaptive Biotechnologies

Adaptive Biotechnologies is a commercial-stage biotech company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature’s most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed to develop products in life sciences research, clinical diagnostics, and drug discovery. We have two commercial products, and a robust clinical pipeline to diagnose, monitor and enable the treatment of diseases such as cancer, autoimmune conditions and infectious diseases. Our goal is to develop and commercialize immune-driven clinical products tailored to each individual patient. For more information, please visit adaptivebiotech.com and follow us on www.twitter.com/adaptivebiotech.       

Investor Contact:
Carrie Mendivil
investors@adaptivebiotech.com 

Media Contact:
Beth Keshishian
media@adaptivebiotech.com 

FAQ

When will Adaptive Biotechnologies present at the BofA Securities Virtual Healthcare Conference?

Adaptive Biotechnologies will present on May 13, 2020, at 12:00 p.m. Pacific Time / 3:00 p.m. Eastern Time.

How can I access the Adaptive Biotechnologies conference presentation?

You can access the live and archived webcast of the presentation on the 'Investors' section of the Adaptive Biotechnologies website.

What is the focus of Adaptive Biotechnologies?

Adaptive Biotechnologies is focused on translating the genetics of the adaptive immune system into clinical products for diagnosing and treating various diseases.

What types of diseases does Adaptive Biotechnologies aim to address?

The company aims to address diseases such as cancer, autoimmune conditions, and infectious diseases.

What is the stock symbol for Adaptive Biotechnologies?

The stock symbol for Adaptive Biotechnologies is ADPT.